4 news items
PainReform Announces Receipt of Nasdaq Minimum Bid Price Notification
PRFX
31 May 24
Communications, LLCTel: 212-671-1021Email
PainReform CEO Ilan Hadar Discusses Latest Developments Related to PRF-110 and its Potential to Help Tackle the Opioid Epidemic on Proactiveinvestors.com
PRFX
8 May 24
Communications, LLCTel: 212-671-1021Email: prfx@crescendo-ir.com Ilan HadarChief Executive
PainReform Announces Closing of $4 Million Public Offering
PRFX
18 Apr 24
and may make with the Securities and Exchange Commission in the future. Contact:Crescendo Communications, LLC
PainReform's Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing Conditions
PRFX
9 Apr 24
with the Securities and Exchange Commission in the future. Contact:Crescendo Communications
- Prev
- 1
- Next